Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials

Br J Haematol. 2019 Apr;185(2):344-347. doi: 10.1111/bjh.15457. Epub 2018 Jul 5.
No abstract available

Keywords: clinical trials; myeloma therapy; new drug development; new drugs for lymphoma.

Publication types

  • Clinical Trial, Phase I
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • London / epidemiology
  • Lymphoma / drug therapy*
  • Lymphoma / mortality
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / mortality
  • Prognosis
  • Treatment Outcome
  • Withholding Treatment / statistics & numerical data

Substances

  • Antineoplastic Agents